4Filed Jun 4, 8:00 PM ET

BrightSpring (BTSG) 10% Owner KKR Phoenix Aggregator Sells $857M

$BTSG · BrightSpring Health Services, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

BrightSpring (BTSG) 10% Owner KKR Phoenix Aggregator Sells $857M

What Happened

  • KKR Phoenix Aggregator L.P., a reported 10% owner of BrightSpring Health Services, Inc. (BTSG), disposed of 14,669,771 shares in connection with an underwritten public offering, receiving a net price of $58.453 per share for total proceeds of $857,492,124.
  • The filing also reports related in-kind distributions/other dispositions of 324,608 shares (code J) and gifts (code G) of 36,927 and 23,263 shares. Footnotes indicate those in-kind distributions were passed to partners/shareholders so the ultimate recipients could make charitable donations; the gifts reflect donations by Messrs. Kravis and Roberts. This is a sale/ disposition activity (not a purchase).

Key Details

  • Transaction date: 2026-06-05 (filed the same day). Net offering price: $58.453 per share; primary sale proceeds: $857,492,124.
  • Primary sale: 14,669,771 shares (code S). Other dispositions: 324,608 shares (code J, $0 proceeds). Gifts: 36,927 and 23,263 shares (code G, $0 proceeds).
  • Shares owned after transaction: not specified in the provided summary of the filing. See the Form 4 for full post-transaction holdings.
  • Notable footnotes: F1 = net price per share from underwritten offering; F4–F6 = in‑kind distributions and subsequent charitable donations by Mr. Kravis and Mr. Roberts; F2–F3 = detailed KKR ownership chain and disclaimer of beneficial ownership.
  • Filing note: multiple affiliates filed separate Form 4s due to EDGAR limits (see remarks).

Context

  • This is institutional/10% owner activity (KKR affiliate), not a company executive trade. Large blocks sold via an underwritten offering often reflect liquidity or portfolio actions rather than a company-management signal.
  • The reported gifts and in-kind distributions are charitable in nature and should not be read as market-timing decisions.